I. Dieussaert

发表

First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector–Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults

P. Klenerman, A. Leach, P. Cicconi, 2019, Clinical Infectious Diseases.

The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity

S. Gatchalian, I. Dieussaert, L. Szenborn, 2009, The Pediatric infectious disease journal.

Kinetics of the immune response following pneumococcal PD conjugate vaccination.

J. Poolman, I. Dieussaert, R. Prymula, 2007, Vaccine.

SAFETY AND IMMUNOGENICITY OF A BOOSTER DOSE OF THE 10-VALENT PNEUMOCOCCAL NONTYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D CONJUGATE VACCINE COADMINISTERED WITH DTPW-HBV/HIB AND POLIOVIRUS VACCINES

S. Gatchalian, I. Dieussaert, L. Szenborn, 2011, The Pediatric infectious disease journal.

Immunogenicity of Twinrix™ in older adults: a critical analysis

M. Lievens, I. Dieussaert, F. André, 2003, Expert review of vaccines.

A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity.

P. van Damme, I. Dieussaert, N. Tornieporth, 2006, Journal of travel medicine.

Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials

P. van Damme, Laurence Fissette, M. Picciolato, 2018, The Journal of infectious diseases.

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

J. Langley, S. Halperin, Laurence Fissette, 2016, The Journal of infectious diseases.

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Serogroup C Conjugate Vaccines

M. Knuf, I. Dieussaert, J. García-Sicilia, 2009, The Pediatric infectious disease journal.

Safety and Immunogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine Coadministered With Measles-Mumps-Rubella-Varicella Vaccine in Children Aged 12 to 16 Months

T. Vesikari, I. Dieussaert, T. Korhonen, 2010, The Pediatric infectious disease journal.

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine

T. Vesikari, I. Dieussaert, H. Czajka, 2009, The Pediatric infectious disease journal.

ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calves

I. Dieussaert, R. de Jong, N. Stockhofe-Zurwieden, 2021, Nature Communications.

Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old.

I. Dieussaert, J. Beran, C. Van Hoecke, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibody persistence and immunologic memory in children vaccinated with 4 doses of pneumococcal conjugate vaccines: Results from 2 long-term follow-up studies

I. Dieussaert, J. Wysocki, J. Brzostek, 2016, Human vaccines & immunotherapeutics.

Immunogenicity of 10-Valent Pneumococcal Nontypeable Haemophilus Influenzae Protein D Conjugate Vaccine When Administered as Catch-up Vaccination to Children 7 Months to 5 Years of Age

T. Vesikari, I. Dieussaert, T. Korhonen, 2011, The Pediatric infectious disease journal.

The Etiological Role of Common Respiratory Viruses in Acute Respiratory Infections in Older Adults: A Systematic Review and Meta-analysis

Mark A. Miller, J. Wedzicha, R. Mikolajczyk, 2019, The Journal of infectious diseases.

Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings

S. Madhi, S. Stoszek, J. Langley, 2022, The Journal of infectious diseases.

Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis.

Mark A. Miller, R. Mikolajczyk, A. Falsey, 2019, The Journal of infectious diseases.

Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized Trial

G. Leroux-Roels, M. Picciolato, I. Dieussaert, 2019, The Journal of infectious diseases.

Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)

M. Knuf, I. Dieussaert, L. Szenborn, 2009, The Pediatric infectious disease journal.

Maternal immunization: where are we now and how to move forward?

I. Dieussaert, T. M. Doherty, A. Vyse, 2018, Annals of medicine.

Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women

D. Apter, M. Picciolato, I. Dieussaert, 2021, The Journal of infectious diseases.

A dynamic transmission model with age-dependent infectiousness and reactivation for cytomegalovirus in the United States: Potential impact of vaccination strategies on congenital infection

C. Hogea, I. Dieussaert, A. Guignard, 2015, Human vaccines & immunotherapeutics.

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.

J. Arístegui, I. Dieussaert, A. Carmona, 2010, Vaccine.

Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.

H. Marshall, I. Dieussaert, C. Flodmark, 2005, Vaccine.

Hamster neogenin, a host-cell protein contained in a respiratory syncytial virus candidate vaccine, induces antibody responses in rabbits but not in clinical trial participants

M. Picciolato, I. Dieussaert, W. Dewé, 2020, Human vaccines & immunotherapeutics.

Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis.

Mark A. Miller, R. Mikolajczyk, M. Lucero, 2020, The Journal of infectious diseases.

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials

D. Vaughn, A. Lindstrand, J. Richardus, 2015, The Pediatric infectious disease journal.

Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents.

J. Arístegui, I. Dieussaert, A. Carmona, 2011, Vaccine.

Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial

Adrian M. Garcia, S. Madhi, J. Langley, 2023, The Journal of infectious diseases.

Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12–23 Months of Age

Andrea A. Berry, N. Chiu, J. Langley, 2022, The Journal of infectious diseases.

Induction of Immunologic Memory Following Primary Vaccination With the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Infants

M. Knuf, I. Dieussaert, A. Habib, 2012, The Pediatric infectious disease journal.

Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children

S. Madhi, S. Stoszek, J. Langley, 2023, Journal of the Pediatric Infectious Diseases Society.

Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies

J. Arístegui, P. Moris, I. Dieussaert, 2015, Human vaccines & immunotherapeutics.

The Etiological Role of Common Respiratory Viruses in Acute Respiratory Infections in Older Adults: A Systematic Review and Meta-analysis

Mark A. Miller, J. Wedzicha, R. Mikolajczyk, 2019, Journal of Infectious Diseases.

RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.

I. Dieussaert, Joon Hyung Kim, Sabine Luik, 2024, The New England journal of medicine.